Compare DrugPatentWatch and Epocrates 
At a Glance
Market Segments
Small-Business (66.7% of reviews)
Enterprise (50.0% of reviews)
Pros & Cons
Not enough data
Not enough data
Entry-Level Pricing
No pricing available
No pricing available
DrugPatentWatch
Star Rating
(6)4.3 out of 5
Market Segments
Small-Business (66.7% of reviews)
Pros & Cons
Not enough data
Entry-Level Pricing
No pricing available
Learn more about DrugPatentWatchEpocrates
Star Rating
(18)4.5 out of 5
Market Segments
Enterprise (50.0% of reviews)
Pros & Cons
Not enough data
Entry-Level Pricing
No pricing available
Learn more about EpocratesDrugPatentWatch vs Epocrates
- Reviewers felt that Epocrates meets the needs of their business better than DrugPatentWatch.
- When comparing quality of ongoing product support, reviewers felt that DrugPatentWatch is the preferred option.
- For feature updates and roadmaps, our reviewers preferred the direction of DrugPatentWatch over Epocrates.
Pricing
Entry-Level Pricing
DrugPatentWatch
No pricing availableEpocrates
No pricing availableFree Trial
DrugPatentWatch
No trial information availableEpocrates
No trial information availableRatings
Meets Requirements
7.7
5
9.1
16
Ease of Use
7.3
5
9.4
16
Ease of Setup
Not enough data
Not enough data
Ease of Admin
Not enough data
Not enough data
Quality of Support
9.7
5
9.0
13
Has the product been a good partner in doing business?
Not enough data
Not enough data
Product Direction (% positive)
10.0
5
8.5
16
Features by Category
Drug Processing
Not enough data
Not enough data
Not enough data
Not enough data
Not enough data
Not enough data
Drug Development
Not enough data
8.3
5
Not enough data
Not enough data
Not enough data
Not enough data
Not enough data
Not enough data
Not enough data
Not enough data
Technology
Not enough data
9.0
5
Not enough data
8.3
5
Categories
Categories
Shared Categories
DrugPatentWatch and Epocrates are categorized as Drug Discovery
Unique Categories
DrugPatentWatch has no unique categories
Epocrates has no unique categories
Reviews
Reviewers' Company Size
DrugPatentWatch
Small-Business(50 or fewer emp.)
Mid-Market(51-1000 emp.)
Enterprise(> 1000 emp.)
Epocrates
Small-Business(50 or fewer emp.)
Mid-Market(51-1000 emp.)
Enterprise(> 1000 emp.)
Small-Business
(50 or fewer emp.)
Mid-Market
(51-1000 emp.)
Enterprise
(> 1000 emp.)
Reviewers' Industry
Pharmaceuticals
50.0%
Research
16.7%
Health, Wellness and Fitness
16.7%
Education Management
16.7%
‐
Other
0.0%
Hospital & Health Care
44.4%
Medical Practice
22.2%
Higher Education
16.7%
Education Management
11.1%
Research
5.6%
Other
0.0%
Alternatives
Discussions
DrugPatentWatch has no discussions with answers
Epocrates has no discussions with answers
Hunting for software insights?
With over 3 million reviews, we can provide the specific details that help you make an informed software buying decision for your business. Finding the right product is important, let us help.
